/Investor DB

Oceanpine Capital

Venture capital

Beijing · Series A–Late Stage · 5 people tracked

Find your way into Oceanpine Capital

Each arrow is one introduction. Sign up to fill in the first one.

472 people can intro you to Dave

Ask Akitaka Wilhelm Fujii to introduce you to Dave Chenn

You →Akitaka · together at GreenSky Ventures →Dave

Sign up to find every way you can get introduced to Oceanpine Capital

  • Your email: who you already know at Oceanpine Capital, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Oceanpine Capital team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Oceanpine Capital is a venture capital firm founded in 2016 with headquarters in Beijing and additional offices in Hong Kong and Silicon Valley. The firm invests in companies operating in semiconductors, artificial intelligence, 5G, IoT, big data, enterprise software, and biotechnology.

Stage
Series A–Late Stage
HQ
Beijing, CN
Instruments
Equity
Founded
2016
AUM
$800M
Tracked investments
3

Team · 5 people

from public directories

What they invest in

from 3 of 3 portfolio companies

Biotech ×2Cloud Computing ×1Deep Tech ×1Hardware ×1Healthtech ×1Medical Devices ×1Semiconductors ×1

HQs:United States×2China×1

Investments · 3 tracked

founders shown can be your intro path
Clounixclounix.com.cn

Clounix designs and develops advanced network and communication chips and software solutions for telecommunications and digital transformation customers, enabling secure next-generation intelligent network infrastructure.

Cloud ComputingDeep TechHardwareSemiconductorsShanghai, CN

Co-investorsQiming Venture PartnersChina Internet Investment FundOndine Capital

Rgenixrgenix.com

BiotechNew York, US

Masoud Tavazoie(Chief Scientific Officer)David Darst(Chief Operating Officer)Isabel Kurth(Vice President - Research)

BoardShahram Seyedin-Noor(Executive Chairman)Nancy Chang(Director)

Co-investors+ND CapitalSofinnova Partners

Triumvira Immunologicstriumvira.comin𝕏Aug 2020 · $55M

Triumvira is a clinical-stage immuno-oncology company developing autologous and allogeneic T cell therapeutics for cancer treatment.

BiotechHealthtechMedical DevicesAustin, US

TERESA MCROBERTS(Executive Officer)inPAUL LAMMERS, MD, MSc(Executive Officer, Director)inJON IRVIN(Executive Officer)in

BoardDANIEL JANSE(Director)JURGEN ECKHARDT(Director)ELIZABETH WILLIAMS(Director)

Co-investorsATEM Capital FundB Capital GroupB4 CapitalCheckmate Capital Group LLCLeaps by BayerNorthpond Ventures

Frequently asked questions

What stage does Oceanpine Capital invest at?
Oceanpine Capital invests at the Series A, Series B, Series C, Late Stage stages.
What sectors does Oceanpine Capital focus on?
Oceanpine Capital focuses on Biotech, Consumer, Data & Infrastructure, EdTech, Enterprise Software, Hardware, Media & Entertainment, SaaS, Semiconductors.
Where is Oceanpine Capital located?
Oceanpine Capital is headquartered in Beijing, CN.

Similar investors

Featured in lists